CASIF — CASI Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $2.26m
- $21.06m
- $20.71m
Annual cashflow statement for CASI Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -35.8 | -40.3 | -26.3 | -39.3 | -48.1 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 10.4 | 23.4 | 10.4 | 6.93 | 7.54 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.22 | -6.65 | -7.82 | 0.771 | 18.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -26.8 | -21.1 | -20 | -29.2 | -20.8 |
| Capital Expenditures | -15.5 | -5.61 | -2.24 | -0.24 | -0.029 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -5.19 | 36.8 | -7.43 | 11.5 | 0.98 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -20.7 | 31.2 | -9.67 | 11.2 | 0.951 |
| Financing Cash Flow Items | -2.02 | — | — | -0.96 | -0.681 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 29.6 | -3.27 | -0.907 | 15.4 | 11.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -18.4 | 8.41 | -30 | -3.62 | -7.84 |